Check out our latest industry white papers. Browse now!
Sales & Support: +1 800 762 3361
Member Resources

GALWAY, IRELAND--August 5, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Pfizer (NYSE:PFE) (New York, New York) and Mylan (NASDAQ:MYL) (Canonsburg, Pennsylvania) are to merge their off-patent drugs businesses into a new company that will have estimated revenues of $19 billion to $20 billion to become the world's largest generic drugmaker. Within this article: Details merger, value of new company, leading products, markets

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)

IIR Logo Globe

Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.

×
×

Contact Us

For More Info!